![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 13, 9186-9192, March 31, 2000
§,
,
,
, and
**
From the The murine F9-derived 1C11 clone exhibits a
stable epithelial morphology, expresses nestin, an early
neuroectodermal marker, and expresses genes involved in neuroectodermal
cell fate. Upon appropriate induction, 100% of 1C11 precursor
cells develop neurite extensions and acquire neuronal markers (N-CAM,
synaptophysin,
Différenciation Cellulaire, CNRS URA
1960, Institut Pasteur, 75724 Paris Cedex 15 France, ¶ Pharma
Research Department, Hoffmann-La-Roche A.G., Basel 40002, Switzerland,
and
CR Claude Bernard, Pathologie Expérimentale et
Communications Cellulaires, IFR 6, Service de Biochimie, Hôpital
Lariboisière, 75010 Paris, France

-enolase, and neurofilament) as well as the
general functions of either serotonergic (1C11*/5HT)
(5HT, 5-hydroxytryptamine) or noradrenergic
(1C11**/NE) (NE, norepinephrine) neurons. The two programs
are shown to be mutually exclusive. 1C11 thus behaves as a
neuroepithelial cell line with a dual bioaminergic fate.
1C11*/5HT cells implement a functional 5-HT transporter and
thereby a complete serotonergic phenotype within 4 days, whereas
5-HT1B/D, 5-HT2B, and 5-HT2A
receptors are sequentially induced. The accurate time schedule of
catecholaminergic differentiation was defined. Catecholamine synthesis,
storage, and catabolism are acquired within 4 days; the noradrenergic
phenotype is complete at day 12 and includes a functional
norepinephrine transporter and an
1D-adrenoreceptor (day
8). The time-dependent onset of neurotransmitter-associated functions proper to either program is similar to in vivo
observations. Along each pathway, the selective induction of
serotonergic or adrenergic receptors is shown to be an essential part
of the differentiation program, since they promote an autoregulation of
the corresponding phenotype.
This article has been cited by other articles:
![]() |
G. Tamguney, K. Giles, D. V. Glidden, P. Lessard, H. Wille, P. Tremblay, D. F. Groth, F. Yehiely, C. Korth, R. C. Moore, et al. Genes contributing to prion pathogenesis J. Gen. Virol., July 1, 2008; 89(7): 1777 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lau, S. Horschitz, S. Berger, D. Bartsch, and P. Schloss Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons FASEB J, June 1, 2008; 22(6): 1702 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MOUILLET-RICHARD, B. SCHNEIDER, E. PRADINES, M. PIETRI, M. ERMONVAL, J. GRASSI, J. G. RICHARDS, V. MUTEL, J.-M. LAUNAY, and O. KELLERMANN Cellular Prion Protein Signaling in Serotonergic Neuronal Cells Ann. N.Y. Acad. Sci., January 1, 2007; 1096(1): 106 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. SCHNEIDER, M. PIETRI, S. MOUILLET-RICHARD, M. ERMONVAL, V. MUTEL, J.-M. LAUNAY, and O. KELLERMANN Control of Bioamine Metabolism by 5-HT2B and {alpha}1D Autoreceptors through Reactive Oxygen Species and Tumor Necrosis Factor-{alpha} Signaling in Neuronal Cells Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 123 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pietri, A. Caprini, S. Mouillet-Richard, E. Pradines, M. Ermonval, J. Grassi, O. Kellermann, and B. Schneider Overstimulation of PrPC Signaling Pathways by Prion Peptide 106-126 Causes Oxidative Injury of Bioaminergic Neuronal Cells J. Biol. Chem., September 22, 2006; 281(38): 28470 - 28479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Launay, B. Schneider, S. Loric, M. Da Prada, and O. Kellermann Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells FASEB J, September 1, 2006; 20(11): 1843 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pietri, B. Schneider, S. Mouillet-Richard, M. Ermonval, V. Mutel, J.-M. Launay, and O. Kellermann Reactive oxygen species-dependent TNF-{alpha} converting enzyme activation through stimulation of 5-HT2B and {alpha}1D autoreceptors in neuronal cells FASEB J, July 1, 2005; 19(9): 1078 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arima, N. Nishida, S. Sakaguchi, K. Shigematsu, R. Atarashi, N. Yamaguchi, D. Yoshikawa, J. Yoon, K. Watanabe, N. Kobayashi, et al. Biological and Biochemical Characteristics of Prion Strains Conserved in Persistently Infected Cell Cultures J. Virol., June 1, 2005; 79(11): 7104 - 7112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mouillet-Richard, M. Pietri, B. Schneider, C. Vidal, V. Mutel, J.-M. Launay, and O. Kellermann Modulation of Serotonergic Receptor Signaling and Cross-talk by Prion Protein J. Biol. Chem., February 11, 2005; 280(6): 4592 - 4601. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schneider, V. Mutel, M. Pietri, M. Ermonval, S. Mouillet-Richard, and O. Kellermann NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells PNAS, November 11, 2003; 100(23): 13326 - 13331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mouillet-Richard, M. Ermonval, C. Chebassier, J. L. Laplanche, S. Lehmann, J. M. Launay, and O. Kellermann Signal Transduction Through Prion Protein Science, September 15, 2000; 289(5486): 1925 - 1928. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |